Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.32 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12765859 | 1.00 | TYMP (0.32) | TYMPSLC6A1SLC6A11 | |
| SCHEMBL13374809 | 1.00 | TYMP (0.32) | TYMPSLC6A1SLC6A11 | |
| SCHEMBL14064222 | 0.98 | TYMP (0.31) | TYMP | |
| SCHEMBL14064224 | 0.93 | TYMP (0.34) | TYMPSLC6A1SLC6A11 | |
| SCHEMBL24829632 | 0.91 | TYMP (0.32) | TYMPSLC6A1SLC6A11 | |
| SCHEMBL25747161 | 0.91 | TYMP (0.32) | TYMPSLC6A1SLC6A11 | |
| SCHEMBL14005196 | 0.90 | TYMP (0.31) | TYMP | |
| SCHEMBL13010078 | 0.87 | — | — | |
| SCHEMBL12765857 | 0.87 | — | — | |
| SCHEMBL12056703 | 0.87 | TYMP (0.32) | TYMPSLC6A1SLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723495-B2 | Amidite for nucleic acid synthesis and nucleic acid synthesizing method | FUJITSU LIMITED (JP) | 2010-05-25 | — | — | US | disclosed |
| US-20090053710-A1 | FUNCTIONAL MOLECULE, FUNCTIONAL MOLECULE SYNTHESIZING AMIDITE AND TARGET SUBSTANCE ANALYSIS METHOD | FUJITSU LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090053710-A1 | FUNCTIONAL MOLECULE, FUNCTIONAL MOLECULE SYNTHESIZING AMIDITE AND TARGET SUBSTANCE ANALYSIS METHOD | TACR1, TACR2, ATIC | TYMP 2415/4885SLC6A1 932/4885SLC6A11 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.